Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)

Rosalie V. Kogan, Bas A. de Jong, Remco J. Renken, Sanne K. Meles, Paul J. H. van Snick, Sandeep Golla, Sjoerd Rijnsdorp, Daniela Perani, Klaus L. Leenders, Ronald Boellaard

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)

Abstract

Introduction: The implementation of spatial-covariance [18F]fluorodeoxyglucose positron emission tomography–based disease-related metabolic brain patterns as biomarkers has been hampered by intercenter imaging differences. Within the scope of the JPND-PETMETPAT working group, we illustrate the impact of these differences on Parkinson's disease–related pattern (PDRP) expression scores. Methods: Five healthy controls, 5 patients with idiopathic rapid eye movement sleep behavior disorder, and 5 patients with Parkinson's disease were scanned on one positron emission tomography/computed tomography system with multiple image reconstructions. In addition, one Hoffman 3D Brain Phantom was scanned on several positron emission tomography/computed tomography systems using various reconstructions. Effects of image contrast on PDRP scores were also examined. Results: Human and phantom raw PDRP scores were systematically influenced by scanner and reconstruction effects. PDRP scores correlated inversely to image contrast. A Gaussian spatial filter reduced contrast while decreasing intercenter score differences. Discussion: Image contrast should be considered in harmonization efforts. A Gaussian filter may reduce noise and intercenter effects without sacrificing sensitivity. Phantom measurements will be important for correcting PDRP score offsets.
Original languageEnglish
Pages (from-to)472-482
Number of pages11
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume11
DOIs
Publication statusPublished - 1 Dec 2019

Keywords

  • FDG-PET
  • Harmonization
  • Hoffman 3D brain phantom
  • Neuroimaging biomarker
  • Principal component analysis

Cite this